It was a pleasure for Serum Life Science Europe GmbH (SLS Europe) to take part in the Niedersächsischer Life Science Tag 2025 in Hannover today, hosted by Niedersachsen.next / BioRegioN.
With the theme “Personalisierte Medizin – Innovationen und Herausforderungen”, the event brought together over 100 experts, innovators, and stakeholders to discuss how precision diagnostics, individualised therapies, and smart translation pathways are shaping the future of healthcare.
Our Managing Director, Dr. Leander Grode, highlighted the critical importance of early regulatory and development strategies in ensuring that innovative therapies reach patients effectively.
A big thank you to the organisers and fellow speakers for a day full of inspiring discussions, practical insights, and exciting startup innovations across RNA therapy, oncology, diagnostics, and natural product development.
At SLS Europe, we remain committed to supporting life science companies in navigating the regulatory landscape for clinical trials, regulatory approval, and product development.
